Machina Capital S.A.S. Abb Vie Inc. Transaction History

Machina Capital S.A.S.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$154.79 - $180.76 $491,148 - $573,551	3,173 Added 61.54%	8,329 $1.43 Million
Q1 2024 May 13, 2024	SELL	$159.82 - $182.1 $987,208 - $1.12 Million	-6,177 Reduced 54.5%	5,156 $938,000
Q4 2023 Feb 06, 2024	BUY	$137.6 - $154.97 $1.56 Million - $1.76 Million	11,333 New	11,333 $1.76 Million
Q2 2023 Aug 08, 2023	BUY	$132.51 - $164.9 $930,750 - $1.16 Million	7,024 Added 1704.85%	7,436 $1 Million
Q1 2023 Apr 24, 2023	SELL	$144.61 - $166.54 $142,874 - $164,541	-988 Reduced 70.57%	412 $65,000
Q4 2022 Feb 08, 2023	BUY	$138.31 - $165.87 $193,634 - $232,218	1,400 New	1,400 $226,000
Q2 2022 Aug 08, 2022	SELL	$137.62 - $174.96 $217,026 - $275,911	-1,577 Reduced 52.97%	1,400 $214,000
Q1 2022 Apr 27, 2022	BUY	$131.98 - $163.75 $392,904 - $487,483	2,977 New	2,977 $483,000
Q1 2020 May 05, 2020	SELL	$64.5 - $97.79 $846,433 - $1.28 Million	-13,123 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$72.13 - $90.25 $946,561 - $1.18 Million	13,123 New	13,123 $1.16 Million
Q2 2019 Jul 19, 2019	SELL	$65.7 - $83.98 $871,839 - $1.11 Million	-13,270 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$77.14 - $90.79 $222,008 - $261,293	2,878 Added 27.69%	13,270 $1.07 Million
Q4 2018 Mar 25, 2019	BUY	$77.85 - $96.01 $809,017 - $997,735	10,392 New	10,392 $958,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Machina Capital S.A.S., based on Form 13F filings with the SEC.

Stay updated on Machina Capital S.A.S. with notifications on news.